Edgar Mulogo Mugema
ID: UNCST-2023-R008170
|
Artemisinin Resistance in Africa: its emergence and evolution in Rwanda and surrounding countries
REFNo: HS3549ES
• 1A will map the regional distribution and define the origins of 561H in Rwanda and neighboring regions in other countries. • 1B will define regional parasite population structure and migration routes that will impact the spread of 561H. • 1C will derive estimates of the selection coefficient for 561H and characterise associated community and infection-related (e.g. polyclonality, known partner drug resistance mutations, within-host relatedness) risk factors.,
|
Uganda |
2024-03-27 13:58:48 |
2027-03-27 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
Clemensia Nakabiito
ID: UNCST-2022-R011396
|
Viiv Protocol 221163: Long-Term Follow-Up of CAB LA for Participants in HPTN 083 and HPTN 084 CAB PrEP Studies at Risk of HIV Acquisition.
REFNo: HS3752ES
Primary Objectives
To describe new HIV infections in adult and adolescent participants at risk of HIV acquisition included in the HPTN 083 and HPTN 084 studies and their associated sub-studies.
Secondary Objectives
To describe any serious adverse events (SAEs), Grade 3 and Grade 4 ISRs and AEs leading to withdrawal in adult and adolescent participants included in the HPTN 083 and HPTN 084 studies and their associated sub-studies.
|
Uganda |
2024-03-26 18:05:15 |
2027-03-26 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
Gertrude Nanyonjo Gawaya
ID: UNCST-2022-R005857
|
Understanding end-user preferences and determining relative product positioning of new and emerging HIV prevention products (LAI-PrEP, bNAbs and HIV vaccines): Development and implementation of a Discrete Choice Experiment among at-risk populations in India and Uganda to inform product development and delivery
REFNo: SS2333ES
Objective 1: To explore and understand end-user preferences for HIV prevention options to design elicitation research (designing DCE)
To identify key attributes (product and delivery site characteristics), and levels (options within a characteristic) through community key stakeholder consultations.
To validate the product attributes and levels in consultation with representatives of potential end-users, non-governmental organisations (NGOs) and community-based organisations (CBOs), and government officials/policymakers for designing preference elicitation research.
Objective 2: To identify end-user preferences for HIV prevention options through elicitation research (DCE implementation)
To quantify the strength of participants’ preferences.
To determine the relative product positioning.
Objective 3: To understand decision-making process involved in choice of products among DCE participants
|
Uganda |
2024-03-26 17:26:24 |
2027-03-26 |
Social Science and Humanities |
Non-Clinical Trial |
Non-degree Award |
|
Proscovia Ntakyo Renzaho
ID:
|
Evaluation of sustainable intensification models for food and nutrition security of small holder households in southwestern highlands of Uganda
REFNo: SS1886ES
3. To understand the interaction effects between livestock and crop intensification on crop productivity in south western highland in Uganda4. To assess the effects of interrelated interventions in crop -livestock production on household food and nutrition security
|
Uganda |
2024-03-26 16:18:44 |
2027-03-26 |
Social Science and Humanities |
Non-Clinical Trial |
Non-degree Award |
|
Dr. Gad Ndaruhutse Ruzaaza
ID: UNCST-2023-R006987
|
Perceptions of a point-of-use water filtration device among individuals of the Kashongi Community
REFNo: HS3490ES
to explore their perceptions of a point-of-use filtration device made using plant matter for filtration,to explore participants’ perceptions of the impact of water quality on their quality of life and the impact of water on their and their family’s health. ,
|
Uganda |
2024-03-26 15:36:54 |
2027-03-26 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
| View |
|
Sort By: |
|
|
|
| |
|